Harpagoside: From Kalahari Desert to pharmacy shelf

Phytochemistry

Volumn 92, Issue , 2013, Pages 8-15

  Georgiev, Milen I ^a   Ivanovska, Nina ^a   Alipieva, Kalina ^b   Dimitrova, Petya ^a   Verpoorte, Robert ^c  

^a INSTITUTE OF MICROBIOLOGY   (Bulgaria)

^b INSTITUTE OF ORGANIC CHEMISTRY   (Bulgaria)

^c LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Anti inflammatory; Anti rheumatic; Biosynthesis; Harpagophytum procumbens; Harpagoside; Iridoid glycosides; Verbascum sp.

Indexed keywords

HARPAGOPHYTUM; HARPAGOPHYTUM PROCUMBENS; PEDALIACEAE; VERBASCUM;

EID: 84884905209     PISSN: 00319422     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phytochem.2013.04.009     Document Type: Short Survey

References (85)

1. Abdelouahab, N., Heard, C., 2008. Effect of the major glycosides of Harpagophytum procumbens (Devil's Claw) on epidermal cyclooxygenase-2 (COX-2) in vitro. J. Nat. Prod. 71, 746-749. (Pubitemid 351841415)
2. Abou-Mandour, A., 1977. Pharmazeutisch-biologische untersuchungen der gattung Harpagophytum. Planta Med. 31, 238-244.
3. Agababyan, E. Yu., Arutyunyan, L.S., Mnatsakanyan, V.A., 1987. Iridoid glycosides of Verbascum laxum. Chem. Nat. Comp. 23, 75-79.
4. Ahmed, B., Al-Rehaily, A.J., Al-Howiriny, T.A., El-Sayed, K.A., Ahmad, M.S., 2003. Scropolioside-D2 and harpagoside-B: two new iridoid glycosides from Scrophularia deserti and their antidiabetic and antiinflammatory activity. Biol. Pharm. Bull. 26, 462-467. (Pubitemid 39663590)
5. Akdemir, Z.S., Tatli, I.I., Bedir, E., Khan, I.A., 2004. Iridoid and phenylethanoid glycosides from Verbascum lasinthum. Turk. J. Chem. 28, 227-234. (Pubitemid 38714041)
6. Anauate, M.C., Torres, L.M., de Mello, S.B., 2010. Effect of isolated fractions of Harpagophytum procumbens D.C. (devil's claw) on COX-1, COX-2 activity and nitric oxide production on whole-blood assay. Phytother. Res. 24, 1365-1369.
7. Andersen, M.L., Santos, E.H., Seabra Mde, L., da Silva, A.A., Tufik, S., 2004. Evaluation of acute and chronic treatments with Harpagophytum procumbens on Freund's adjuvant-induced arthritis in rats. J. Ethnopharmacol. 91, 325-330. (Pubitemid 38561131)
8. Arrigoni-Martelli, E., 1977. Inflammation and Antiinflammatories. Spectrum Publications, New York.
9. Baghdikian, B., Lanhers, M.C., Fleurentin, J., Ollivier, E., Maillard, C., Balansard, G., Mortier, F., 1997. An analytical study, anti-inflammatory and analgesic effects of Harpagophytum procumbens and Harpagophytum zeyheri. Planta Med. 63, 171-176. (Pubitemid 27196089)
10. Boeckenholt, C., Begrow, F., Verspohl, E.J., 2012. Effect of silymarin and harpagoside on inflammation reaction of BEAS-2B cells, on ciliary beat frequency (CBF) of trachea explants and on mucociliary clearance (MCC). Planta Med. 78, 761-766.
11. Boje, K., Lechtenberg, M., Nahrstedt, A., 2003. New and known iridoid- and phenylethanoid glycosides from Harpagophytum procumbens and their in vitro inhibition of human leukocyte elastase. Planta Med. 69, 820-825. (Pubitemid 37346569)
12. Breedveld, F.C., Combe, B., 2011. Understanding emerging treatment paradigms in rheumatoid arthritis. Arthritis Res. Ther. 13, S3.
13. Burger, J.F.W., Brandt, E.V., Ferreira, D., 1987. Iridoid and phenolic glycosides from Harpagophytum procumbens. Phytochemistry 26, 1453-1457.
14. Chrubasik, S., Thanner, J., Kunzel, O., Conradt, C., Black, A., Pollak, S., 2002. Comparison of outcome measures during treatment with the proprietary Harpagophytum extract doloteffin in patients with pain in the lower back, knee or hip. Phytomedicine 9, 181-194. (Pubitemid 34475549)
15. Chrubasik, S., Conradt, C., Black, A., 2003. The quality of clinical trials with Harpagophytum procumbens. Phytomedicine 10, 613-623. (Pubitemid 37092691)
16. Chrubasik, S., 2004. Devil's claw extract as an example of the effectiveness of herbal analgesics. Orthopäde 33, 804-808. (Pubitemid 39005991)
17. Chrubasik, S., Kunzel, O., Thanner, J., Conradt, C., Black, A., 2005. A 1-year follow-up after a pilot study with Doloteffin for low back pain. Phytomedicine 12, 1-9. (Pubitemid 40174322)
18. Chrubasik, S., Chrubasik, C., Kunzel, O., Black, A., 2007a. Patient-perceived benefit during one year of treatment with Doloteffin. Phytomedicine 14, 371-376. (Pubitemid 46818016)
19. Chrubasik, J.E., Roufogalis, B.D., Chrubasik, S., 2007b. Evidence of effectiveness of herbal antiinflammatory drugs in the treatment of painful osteoarthritis and chronic low back pain. Phytother. Res. 21, 675-683. (Pubitemid 47066785)
20. Circosta, C., Occhiuto, F., Ragusa, S., Trovato, A., Tumino, G., Briguglio, F., de Pasquale, A., 1984. A drug used in traditional medicine: Harpagophytum procumbens DC. II. Cardiovascular activity. J. Ethnopharmacol. 11, 259-274. (Pubitemid 14045964)
21. Costa De Pasquale, R., Busa, G., Circosta, C., Iauk, L., Ragusa, S., Ficarra, P., Occhiuto, F., 1985. A drug used in traditional medicine: Harpagophytum procumbens DC. III. Effects on hyperkinetic ventricular arrhythmias by reperfusion. J. Ethnopharmacol. 13, 193-199. (Pubitemid 15035531)
22. Czygan, F.-C., Krüger, A., 1977. Pharmaceutisch-biologische untersuchungen der gattung Harpagophytum-3. Mitteilung: Zur verteilung des iridoid-glycosids harpagosid in den einzelnen organen von Harpagophytum procumbens DC und Harpagophytum zeyheri Decne. Planta Med. 31, 305-307. (Pubitemid 8108554)
23. Damtoft, S., Jensen, S.R., Jessen, C.U., Knudsen, T.B., 1993. Late stages in the biosynthesis of aucubin in Scrophularia. Phytochemistry 33, 1089-1093.
24. Damtoft, S., Jensen, S.R., Weiergang, I., 1994. Early stages in the biosynthesis of aucubin and harpagide. Deuterium labelling studies. Phytochemistry 35, 621-622. (Pubitemid 2044160)
25. Dimitrova, P., Georgiev, M.I., Khan, M.T.H., Ivanovska, N., 2013. Evaluation of Verbascum species and harpagoside in models of acute and chronic inflammation. Cent. Eur. J. Biol. 8, 186-194.
26. Eichler, O., Koch, C., 1970. Antiphlogistic, analgesic and spasmolytic effect of harpagoside, a glycoside from the root of Harpagophytum procumbens DC. Arzneimittelforschung 20, 107-109.
27. Emam, S.S., 2010. Glycosides of Verbascum letorneuxii, asch. and its antioxidant activity. Aust. J. Basic Appl. Sci. 4, 5038-5050.
28. Fernandez, L., Diaz, A.M., Velazquez, M.P., Rubio, B., 1992. Popylphenolic compounds in Scrophularia scorodonia L. ARS Pharm. 33, 449-451.
29. Fiebich, B.L., Heinrich, M., Hiller, K.O., Kammerer, N., 2001. Inhibition of TNF-alpha synthesis in LPS-stimulated primary human monocytes by Harpagophytum extract Stei Hap 69. Phytomedicine 8, 28-30. (Pubitemid 32242089)
30. Fiebich, B.L., Munoz, E., Rose, T., Weiss, G., McGregor, G.P., 2012. Molecular targets of the antiinflammatory Harpagophytum procumbens (devil's claw): inhibition of TNFalpha and COX-2 gene expression by preventing activation of AP-1. Phytother. Res. 26, 806-811.
31. Firestein, G.S., 2003. Evolving concepts of rheumatoid arthritis. Nature 423, 356-361. (Pubitemid 40852711)
32. Franz, G., Czygan, F.-C., Abou-Mandour, A.A., 1982. Untersuchungen der gattung Harpagophytum. 4. Mitteilung: gehalt an freien zuckern und harpagosid in kalluskulturen und genuinen wurzelgeweben von Harpagophytum procumbens. Planta Med. 44, 218-220. (Pubitemid 12093666)
33. Gagnier, J.J., van Tulder, M.W., Berman, B., Bombardier, C., 2004. Harpgophytum procumbens for osteoarthritis and low back pain: a systematic review. BMC Complement. Altern. Med. 4, 13.
34. Garcia, D., Fernandez, A., Saenz, T., Ahumada, C., 1996. Antiinflammatory effects of different extracts and harpagoside isolated from Scrophularia frutescens L. Farmaco 51, 443-446. (Pubitemid 26266724)
35. Garg, H.S., Bhandari, S.P.S., Tripathi, S.C., Patnaik, G.K., Puri, A., Saxena, R., Saxena, R.P., 1994. Antihepatotoxic and immunostimulant properties of iridoid glycosides of Scrophularia koelzii. Phytother. Res. 8, 224-228. (Pubitemid 24195159)
36. Georgiev, M.I., Ali, K., Alipieva, K., Verpoorte, R., Choi, Y.H., 2011. Metabolic differentiations and classification of Verbascum species by NMR-based metabolomics. Phytochemistry 72, 2045-2051.
37. Georgiev, M.I., Agostini, E., Ludwig-Müller, J., Xu, J., 2012a. Genetically transformed roots: from plant disease to biotechnological resource. Trends Biotechnol. 30, 528-537.
38. Georgiev, M.I., Pastore, S., Lulli, D., Alipieva, K., Kostyuk, V., Potapovich, A., Panetta, M., Korkina, L., 2012b. Verbascum xanthophoeniceum- derived phenylethanoid glycosides are potent inhibitors of inflammatory chemokines in dormant and interferon-gamma-stimulated human keratinocytes. J. Ethnopharmacol. 144, 754-760.
39. Grabkowska, R., Krolicka, A., Mielicki, W., Wielanek, M., Wysokinska, H., 2010. Genetic transformation of Harpagophytum procumbens by Agrobacterium rhizogenes: iridoid and phenylethanoid glycoside accumulation in hairy root cultures. Acta Physiol. Plant. 32, 665-673.
40. Grahame, R., Robinson, B.V., 1981. Devils's claw (Harpagophytum procumbens): pharmacological and clinical studies. Ann. Rheum. Dis. 40, 632. (Pubitemid 12177270)
41. Gunther, M., Laufer, S., Schmidt, P.C., 2006. High anti-inflammatory activity of harpagoside-enriched extracts obtained from solvent-modified super- and subcritical carbon dioxide extractions of the roots of Harpagophytum procumbens. Phytochem. Anal. 17, 1-7. (Pubitemid 43141391)
42. Gyurkovska, V., Alipieva, K., Maciuk, A., Dimitrova, P., Ivanovska, N., Haas, C., Bley, T., Georgiev, M.I., 2011. Anti-inflammatory activity of Devil's claw in vitro systems and their active constituents. Food Chem. 125, 171-178.
43. Haznagy-Radnai, E., Czigle, S., Janicsak, G., Mathe, I., 2006. Iridoids of Stachys species growing in Hungary. J. Planar Chromatogr. Mod. TLC 26, 505-509.
44. Haznagy-Radnai, E., Balogh, A., Czigle, S., Mathe, I., Hohmann, J., Blazso, G., 2012. Antiinflammatory activities of Hungarian Stachys species and their iridoids. Phytother. Res. 26, 505-509.
45. Huang, T.H., Tran, V.H., Duke, R.K., Tan, S., Chrubasik, S., Roufogalis, B.D., Duke, C.C., 2006. Harpagoside suppresses lipopolysaccharide-induced iNOS and COX-2 expression through inhibition of NF-kappa B activation. J. Ethnopharmacol. 104, 149-155. (Pubitemid 43234097)
46. Inaba, K., Murata, K., Naruto, S., Matsuda, H., 2010. Inhibitory effects of devil's claw (secondary root of Harpagophytum procumbens) extract and harpagoside on cytokine production in mouse macrophages. J. Nat. Med. 64, 219-222.
47. Jang, M.H., Lim, S., Han, S.M., Park, H.J., Shin, I., Kim, J.W., Kim, N.J., Lee, J.S., Kim, K.A., Kim, C.J., 2003. Harpagophytum procumbens suppresses lipopolysaccharidestimulated expressions of cyclooxygenase-2 and inducible nitric oxide synthase in fibroblast cell line L929. J. Pharmacol. Sci. 93, 367-371. (Pubitemid 37521360)
48. Jensen, S.R., Li, H.Q., Albach, D.C., Gotfredsen, C.H., 2008. Phytochemistry and molecular systematics of Triaenophora rupestris and Oreosolen wattii (Scrophulariaceae). Phytochemistry 69, 2162-2166.
49. Kajimoto, T., Hidaka, M., Shoyama, K., Nohara, T., 1989. Iridoids from Scrophularia ningpoensis. Phytochemistry 28, 2701-2704.
50. Karioti, A., Fani, E., Vincieri, F.F., Bilia, A.R., 2011. Analysis and stability of the constituents of Curcuma longa and Harpagophytum procumbens tinctures by HPLC-DAD and HPLC-ESI-MS. J. Pharm. Biomed. Anal. 55, 479-486.
51. Kaszkin, M., Beck, K.F., Koch, E., Erdelmeier, C., Kusch, S., Pfeilschifter, J., Loew, D., 2004. Downregulation of iNOS expression in rat mesangial cells by special extracts of Harpagophytum procumbens derives from harpagoside-dependent and independent effects. Phytomedicine 11, 585-595. (Pubitemid 40007740)
52. Kim, S.R., Lee, K.Y., Koo, K.A., Sung, S.H., Lee, N.-G., Kim, J., Kim, Y.C., 2002. Four new neuroprotective iridoid glycosides from Scrophularia buergeriana roots. J. Nat. Prod. 65, 1696-1699. (Pubitemid 35386810)
53. Kundu, J.K., Mossanda, K.S., Na, H.K., Surh, Y.J., 2005. Inhibitory effects of the extracts of Sutherlandia frutescens (L.) R. Br. and Harpagophytum procumbens DC. on phorbol ester-induced COX-2 expression in mouse skin: AP-1 and CREB as potential upstream targets. Cancer Lett. 218, 21-31. (Pubitemid 40082698)
54. Lanhers, M.C., Fleurentin, J., Mortier, F., Vinche, A., Younos, C., 1992. Antiinflammatory and analgesic effects of an aqueous extract of Harpagophytum procumbens. Planta Med. 58, 117-123.
55. Lee, M.K., Choi, O.-G., Park, J.-H., Cho, H.-J., Ahn, M.-J., Kim, Y.C., Sung, S.H., 2007. Simultaneous determination of four active constituents in roots of Scrophularia buergeriana by HPLC-DAD and LC-ESI-MS. J. Sep. Sci. 30, 2345-2350. (Pubitemid 350020031)
56. Levieille, G., Wilson, G., 2002. In vitro propagation and iridoid analysis of the medicinal species Harpagophytum procumbens and H. zeyheri. Plant Cell Rep. 21, 220-225. (Pubitemid 36059293)
57. Lichti, H., von Wartburg, A., 1966. Die struktur des harpagosids. Helv. Chim. Acta 49, 1552-1580.
58. Lin, H.-M., Chen, S.-M., Chen, C.-C., Tsay, H.S., 1998. Mass propagation of Scrophularia yoshimurae Yamazaki by tissue culture. J. Agric. Assoc. China 183, 10-12. (Pubitemid 128759806)
59. Loew, D., Mollerfeld, J., Schrodter, A., Puttkammer, S., Kaszkin, M., 2001. Investigations on the pharmacokinetic properties of Harpagophytum extracts and their effects on eicosanoid biosynthesis in vitro and ex vivo. Clin. Pharmacol. Ther. 69, 356-364. (Pubitemid 32477077)
60. Ludwig-Müller, J., Georgiev, M.I., Bley, Th., 2008. Metabolite and hormonal status of hairy root cultures of Devil's claw (Harpagophytum procumbens) in flasks and in a bubble column bioreactor. Process Biochem. 43, 15-23. (Pubitemid 350257022)
61. Luyten, F.P., Lories, R.J., Verschueren, P., de Vlam, K., Westhovens, R., 2006. Contemporary concepts of inflammation, damage and repair in rheumatic diseases. Best Pract. Res. Clin. Rheumatol. 20, 829-848. (Pubitemid 44356463)
62. Mahomed, I.M., Ojewole, J.A., 2004. Analgesic, antiinflammatory and antidiabetic properties of Harpagophytum procumbens DC (Pedaliaceae) secondary root aqueous extract. Phytother. Res. 18, 982-989. (Pubitemid 40278922)
63. Mncwangi, N., Chen, W., Vermaak, I., Viljoen, A.M., Gericke, N., 2012. Devil's claw - a review of the ethnobotany, phytochemistry and biological activity of Harpagophytum procumbens. J. Ethnopharmacol. 143, 755-771.
64. Oudin, A., Courtois, M., Rideau, M., Clastre, M., 2007. The iridoid pathway in Catharanthus rouseus alkaloid biosynthesis. Phytochem. Rev. 6, 259-276. (Pubitemid 46870976)
65. Ouitas, N.A., Heard, C.M., 2009. A novel ex vivo skin model for the assessment of the potential transcutaneous anti-inflammatory effect of topically applied Harpagophytum procumbens extract. Int. J. Pharm. 376, 63-68.
66. Ouitas, N.A., Heard, C.M., 2010. Estimation of the relative antiinflammatory efficacies of six commercial preparations of Harpagophytum procumbens (Devil's claw). Phyother. Res. 24, 333-338.
67. Pachaly, P., Barion, J., Sin, K.S., 1994. Isolation and analysis of new iridoids from roots of Scrophylaria korainensis. Pharmazie 49, 150-155. (Pubitemid 24093102)
68. Potterat, O., Saadou, M., Hostettmann, K., 1991. Iridoid glucosides from Rogeria adenophylla. Phytochemistry 30, 889-892.
69. Qi, J., Chen, J.J., Cheng, Z.H., Zhou, J.H., Yu, B.Y., Qiu, S.X., 2006. Iridoid glycosides from Harpagophytum procumbens D.C. (devil's claw). Phytochemistry 67, 1372-1377. (Pubitemid 44080273)
70. Recio, M.C., Giner, R.M., Manez, S., Rios, J.L., 1994. Structural considerations on the iridoids as anti-inflammatory agents. Planta Med. 60, 232-234. (Pubitemid 24207715)
71. Sampaio-Santos, M.I., Kaplan, M.A.C., 2001. Biosynthesis significance of iridoids in chemosystematics. J. Br. Chem. Soc. 12, 144-153.
72. Seifert, K., Schmidt, J., Lien, N.T., Johne, S., 1985. Iridoide aus Verbascum-Arten. Plant Med. 5, 409-411. (Pubitemid 16253777)
73. Sesterhenn, K., Distl, M., Wink, M., 2007. Occurrence of iridoid glycosides in in vitro cultures and intact plants of Scrophularia nodosa L. Plant Cell Rep. 26, 365-371.
74. Soulimani, R., Younos, C., Mortier, F., Derrieu, C., 1994. The role of stomachal digestion on the pharmacological activity of plant extracts, using as an example extracts of Harpagophytum procumbens. Can. J. Physiol. Pharmacol. 72, 1532-1536.
75. Spelman, K., Burns, J., Nichols, D., Winters, N., Ottersberg, S., Tenborg, M., 2006. Modulation of cytokine expression by traditional medicines: a review of herbal immunomodulators. Altern. Med. Rev. 11, 128-150. (Pubitemid 44050251)
76. Sporer, F., Chrubasik, S., 1999. Praparate aus der Teufelskralle (Harpagophytum procumbens). Zschr. Phytother. 20, 235-236.
77. Stewart, K.M., Cole, D., 2005. The commercial harvest of devil's claw (Harpagophytum spp.) in southern Africa: the devil's in the details. J. Ethnopharmacol. 100, 225-236. (Pubitemid 41206616)
78. Sun, X., Xiong, Z., Zhang, Y., Meng, Y., Xu, G., Xia, Z., Li, J., Zhang, R., Ke, Z., Hu, Y., 2012. Harpagoside attenuates MPTP/MPP(+) induced dopaminergic neurodegeneration and movement disorder via elevating glial cell linederived neurotrophic factor. J. Neurochem. 120, 1072-1083.
79. Tian, J., Ye, X., Shang, Y., Deng, Y., He, K., Li, X., 2012. Preparative isolation and purification of harpagoside and angroside C from the root of Scrophularia ningpoensis Hemsley by high-speed counter-current chromatography. J. Sep. Sci. 35, 2659-2664.
80. Tong, S., Yan, J., Lou, J., 2006. Preparative isolation and purification of harpagoside from Scrophularia ningpoensis Hemsley by high-speed counter-current chromatography. Phytochem. Anal. 17, 406-408. (Pubitemid 44697748)
81. Tunmann, P., Lux, R., 1962. Zur Kenntniss der Inhaltsstoffe aus der Wurzel von H.p. Dtsch. Apoth. Ztg. 102, 1274-1275.
82. Velazquez-Fiz, M.P., Diaz-Lanza, A.M., Fernandez-Matellano, L., 2000. Iridoids from Plantago lagopus. Pharm. Biol. 38, 268-270.
83. Viljoen, A.M., Mncwangi, N., Vermaak, I., 2012. Anti-inflammatory iridoids of botanical origin. Curr. Med. Chem. 19, 2104-2127.
84. Whitehouse, L.W., Znamirowska, M., Paul, C.J., 1983. Devil's Claw (Harpagophytum procumbens): no evidence for anti-inflammatory activity in the treatment of arthritic disease. Can. Med. Assoc. J. 129, 249-251. (Pubitemid 13033743)
85. Yuan, Q.-M., Yang, H.-M., Zhao, J.-F., Li, L., 2011. One new iridoid from Hedyotis tenelliflora. Chin. Tradit. Herb. Drugs 42, 1464-1466.